UTA FAMILY 3 LATEST 2026 PRACTICE EXAM QUESTIONS AND SOLUTIONS RATED A.pdf

UTA FAMILY 3 LATEST 2026 PRACTICE EXAM
QUESTIONS AND SOLUTIONS RATED A+
✔✔2017 ACC/AHA guidelines: clinical CVD and BP ≥ 130 / ≥ 80 - ✔✔use BP lowering
meds

✔✔2017 ACC/AHA guidelines: primary prevention in adults 10 yr ASCVD risk of ≥ 10%
- ✔✔use BP lowering meds

✔✔2017 ACC/AHA guidelines: 10 yr risk < 10% and SBP ≥ 140/90 - ✔✔use BP
lowering meds

✔✔2017 ACC/AHA guidelines: normal BP reassessment - ✔✔yearly

✔✔2017 ACC/AHA guidelines: elevated BP reassessment - ✔✔3-6 months

✔✔2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD < 10% -
✔✔3-6 months

✔✔2017 ACC/AHA guidelines: stage 2 HTN reassessment - ✔✔one month until goal
BP met, then 3-6 months

✔✔2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD > 10% -
✔✔one month until BP goal met, then 3-6 months

✔✔What hypertensive medications should not be prescribed simultaneously? - ✔✔-
ACE
- ARB
- Renin Inhibitor

✔✔2017 ACC/AHA guidelines: first line agents - ✔✔- thiazide diuretics
- CCBs
- ACE
- ARBs

✔✔2017 ACC/AHA guidelines: initiation of drug therapy in stage 2 HTN - ✔✔initiate
drug therapy with 2 first line medications of different classes as separate agents or
combo drug

✔✔2017 ACC/AHA guidelines: initiation of drug therapy in stage 1 HTN - ✔✔initiate
therapy with a single drug

✔✔2017 ACC/AHA guidelines: HTN reassessment for new or adjusted drug regimen -
✔✔follow up at monthly intervals until control is sustained

, ✔✔2017 ACC/AHA guidelines: black adults with HTN, no HF or CKD - ✔✔initiate
therapy with thiazide diuretic or CCB

✔✔2017 ACC/AHA guidelines: pregnant or planning pregnancy safe drug choice - ✔✔-
methyldopa
- nifedipine
- labetalol

✔✔2017 ACC/AHA guidelines: drugs contraindicated in pregnant women - ✔✔- ACE
- ARBs
- direct renin inhibitors

✔✔2017 ACC/AHA vs JNC 8 older community dwelling adults ≥ 65 yo - ✔✔- JNC 8
treat BP if > 150/90
- 2017 treat if SBP ≥ 130

✔✔2017 ACC/AHA guidelines: hypertensive crisis - ✔✔> 180/120
admit to ICU if target organ damage

✔✔2017 ACC/AHA guidelines: secondary stroke prevention BP threshold - ✔✔≥ 140/90

✔✔2017 ACC/AHA guidelines: no CVD and ASCVD risk < 10% BP threshold - ✔✔≥
140/90

✔✔TOD brain - ✔✔- CVA
- encephalopathy
- dementia
- multi infarct
- early cognitive decline

✔✔TOD eyes - ✔✔- flame hemorrhage
- papilloedema
- hard exudates
- cotton wool spots

✔✔TOD heart - ✔✔- LVH
- CAD
- MI
- rhythm disorders
- aortic and PAD
- AAA

✔✔TOD kidneys - ✔✔- CKD
- GFR < 60